A
Aldeyra Therapeutics (ALDX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aldeyra Therapeutics (ALDX)
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in developing immune-modulating therapies to treat ocular and systemic diseases. The Company's lead product candidate, reproxalap, is a treatment in late-stage development for dr... Read more
- USD3.79
- USD4.04
- USD3.73
- USD7.20
- 78.10%
- --
- 922.98k
- 889.76k
- 227M
- 1.14
- 15.70%
Stock News
yesterday
An upgrade for Apple’s stock? It’s not the endorsement you might think.
MarketWatch
yesterday
Jim Cramer explains how Microsoft, Meta and Nvidia led the Mag 7 pack in the first half of 2025
CNBC
yesterday
Bank of America Comments on Stress Test Results; Plans to Increase Quarterly Dividend 8% to $0.28 Per Share
Yahoo
yesterday
Mark Zuckerberg's costly AI talent push has not cost Meta stock yet. Here's why
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
